Combination Therapy of Interferon Alfa-2b Plus Interleukin 2 and Hepatitis B Vaccine in Entecavir-experienced Chronic Hepatitis B Patients With HBeAg Seroclearance: a Prospective, Randomized Open-label Trial (Endeavor Study, a Pilot Study)
Phase of Trial: Phase IV
Latest Information Update: 02 Nov 2017
At a glance
- Drugs Entecavir (Primary) ; Hepatitis B vaccines; Interferon alpha-2b; Interleukin-2
- Indications Hepatitis B
- Focus Proof of concept; Therapeutic Use
- Acronyms ENDEAVOR
- 24 Oct 2017 Results presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases
- 15 Jun 2016 Planned End Date changed from 1 Jul 2016 to 1 Jun 2017.
- 15 Jun 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Dec 2016.